Sponsor Pipeline

Atlas Molecular Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07024316 A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions… Congenital Erythropoietic Porphyria (CEP) Recruiting
Get alerts when Atlas Molecular Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free